Innovative Phytosomal Carriers: Transforming Herbal Extracts Into High-Performance Therapeutics

Throughout the past century, important standards have been maintained and focused on the development of innovative drug delivery systems (NDDS) for herbal remedies. Scholars have affirmed the innovative medication delivery's potential benefits in offering significant improvements in drug delivery and targeting. Patients stand to gain greatly from improved delivery methods, less toxicity, and increased efficacy, which also opens up new markets for pharmaceutical and medicine companies. The new carriers should route the active ingredient of the herbal medication to the site of action and supply the medication at a rate determined by the body's needs during the course of treatment.[1]

A unique drug delivery system is an innovative method of delivering drugs that overcomes the drawbacks of conventional drug delivery systems. The potential of the extensive Ayurvedic knowledge base in our nation has only just come to light. The treatment's effectiveness is diminished, nevertheless, because the drug administration method employed to give the patient the herbal remedy is antiquated and conventional. The use of innovative medication delivery technology in herbal medicine may improve the effectiveness and lessen the negative effects of different herbal compounds and herbs. This is the fundamental concept underlying the use of innovative drug delivery techniques in herbal remedies. To tackle more serious ailments, it is crucial to combine Indian Ayurvedic remedies with innovative drug delivery systems. Due to a lack of scientific support and processing challenges, including standardization, extraction, and identification of specific medicinal components in intricate polyherbal systems, herbal medicines were long disregarded for development as innovative formulations. Nonetheless, contemporary phytopharmaceutical research can address the scientific requirements (e.g., pharmacokinetics, mechanism of action, site of action, precise dosage needed, etc.) for herbal medicines to be integrated into innovative drug delivery systems, including solid dispersions, liposomes, solid lipid nanoparticles, microemulsions, matrix systems, nanoparticles, and so forth. This page provides examples and a summary of several drug delivery strategies that can be applied to herbal active ingredients.[2]

The majority of the polar or water-soluble biologically active components found in plants are limited in their use because of absorption issues, which eventually lowers their bioavailability.Herbal products must have the right balance between hydrophilic (for absorption) and hydrophilic components in order to increase bioavailability. into the fluid of the gastrointestinal system) and lipophilic (to break the balance of lipid biomembranes). Both ancient and modern medical systems make extensive use of plant preparations. Many plant extracts and their constituents have been the subject of numerous pharmacological research throughout history to examine their potential for medicinal use. The creation of innovative drug delivery systems (NDDS) for different plant extracts and their active ingredients has advanced significantly during the last 12 months. Innovative drug delivery methods, such targeted drug delivery, which directly channels the active ingredient to the site of action, may provide tailored and sustained drug release, enabling pharmacological effects at lower dosages. Herbal medicine began to advance earlier in order to treat human illnesses with fewer adverse effects.[3]

"Some" refers to a structure that resembles cells, whereas "phyto" refers to a plant. This invention was created and introduced with a patent by Nutraceuticals®, a top producer of herbal medications. The low oral bioavailability of many plants, particularly those with polyphenolic rings in their structures like flavonoids and other water-soluble constituents like terpenoids and tannins, has raised concerns among researchers and scholars regarding the bioavailability of plant active principles. These compounds' poor bioavailability can be attributed to a number of fundamental factors, including low lipid or water solubility, high molecular. low permeability of the plasma membrane and weight/size. In order to address these issues and make herbal therapy more Due to their effectiveness, these medications have recently been added to a number of innovative delivery systems. Creating nanoparticles at the nanoscale, binding with lipids to form liposomes or herbosomes/phytosomes, delivering the drug as a prodrug, modifying chemical structures, and complexing with cyclodextrins are a few methods for increasing bioavailability.[4]

One innovative method of drug administration is phytosomes, which are useful for administering herbal medications at a fixed rate. at the scene of the incident, reduces harmful effects, increases a drug's absorption, medication distribution can be controlled by either adding the medication to a carrier system or altering the drug's molecular structure. Because of its uses and safety features, herbal drugs are growing in popularity in the modern world. (Awasthi and others, 2011) Phytosomes are recently produced and incorporated standardized plant extracts using patented technology from India. (Awasthi and others, 2011) A tiny cell is created during the phytosomes process, and as a result, the important components of the Herbal extracts are shielded from gut microbes and digestive fluids. Phytosomes are more adept in moving from a hydrophilic environment into the enterocyte cell membrane's lipid-friendly environment, and then into the cell until it reaches the blood. The pharmacokinetic and pharmacological parameters of phytosomes have been enhanced. Because of their improved ability to pass through lipid-rich biomembranes and eventually enter the bloodstream, phytosomes have a higher bioavailability than herbal extracts. Phospholipids are phosphatidylcholine. It is essential to the process of phytosomes. Phospholipids are used as carriers for lipid- and water-soluble nutrients as well as natural digestion aids.[5]

PROPERTIES OF PHYTOSOMES

PHYSICOCHEMICAL PROPERTIES

As was previously mentioned, a standardized plant extract is used as the substrate in a reaction with a stoichiometric amount of phospholipid to create phytosomes. As demonstrated by the spectroscopic data, the phospholipid-substrate contact results from the polar head (phosphate and ammonium group) and the polar characteristics of the substrate. Phytosomes range in size from 50 nm to a few hundred µm. When phytosomes are exposed to water, they take on a micellar shape that resembles a liposome. These liposomal structures are visible by Photon Correlation Spectroscopy (PCS). The fatty chain provides unaltered signals in both the complex and free phospholipid, according to the 1HNMR and 13CNMR data. This suggests that lengthy aliphatic chains are encircling the active principle to form a lipophilic envelope. The complexes are frequently easily soluble in aprotic solvents, moderately soluble in lipids, insoluble in water, and somewhat unstable in alcohol, according to the solubility of phytosomes. However, as will be covered later in this study, the phytosomes of some lipophilic phytoconstituents, such as curcumin, have demonstrated enhanced water solubility upon complexation with phospholipids.[3]

CHEMICAL PROPERTIES

A natural substance and natural phospholipids, such as soy phospholipids, combine to form phytosomes. The stoichiometric reaction produces such a complex quantities of phospholipid in a nonpolar solvent along with the chosen polyphenol (such as simple flavonoids). It has been demonstrated that the primary phospholipid-substrate interaction results from the creation of hydrogen bonds between the polar functional groups of the substrate and the polar head of phospholipids, or phosphate and ammonium groups, based on their physicochemical and spectroscopic data. These molecules are lipophilic, have a clear melting point, are moderately soluble in fats, and are easily soluble in nonpolar solvents (whereas the hydrophilic moiety was not). Phytosomes take on a micellar shape and form structures resembling liposomes when exposed to water. The active ingredient in liposomes either floats in the layer membrane or dissolves in an interior pocket. In contrast, the active principle in phytosomes is linked to the phospholipids' polar head and forms an essential component of the membrane. Certain spectroscopic techniques can show that molecules are linked to the polar head of the phospholipids by chemical bonds.[6]

BIOLOGICAL PROPERTIES

The biological behavior of phytosomes has been demonstrated through pharmacokinetic and pharmacodynamic studies conducted on human subjects and experimental animals. These studies have assessed the phytosomes' higher bioavailability compared to the non-complexed botanical derivatives.[6]

1. When taken orally, phytosomes enhance the overall bioavailability and active absorption of active substances.
2. These are more advanced forms of herbal products that are more effective than traditional herbal extracts.
3. The pharmacokinetics of phytosomes are superior to those of basic herbal medications.
4. Phytosomes are sophisticated herbal medicines that work better than traditional herbal extracts because they are more easily absorbed and used.
5. Lipophilic compounds with a distinct melting point, phytosomes are easily soluble in non-polar solvents and only weakly soluble in lipids.
6. The active principle, which is attached to the polar head of the phospholipids and ultimately forms an essential component of the membrane, can be accommodated by phytosomes.
7. Pharmacokinetics studies or pharmacodynamic tests in experimental animals and human subjects have shown that the phytosome has a higher bioavailability than the non-complexed botanical derivatives.[7]

PHOSPOLIPIDS

Plant seeds and egg yolks are rich sources of phospholipids. Phospholipids made in an industrial setting are currently accessible. Glycerophospholipids are a subset of phospholipids. and, depending on the backbone, sphingomyelins. Phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidic acid (PA), phosphatidylinositol (PI), and phosphatidylglycerol (PG) are further examples of glycerophospholipids.[8] The majority of cell membranes include phospholipids, also known as complex lipids, which are amphiphilic molecules that contain both hydrophilic and hydrophobic fatty acid chains. The capacity of polar moieties to interact is significantly influenced by PH. Phospholipids get hydrated and take on lamellar or hexagonal phases when they come into contact with water. Additionally, the phospholipids serve as an emulsifier. Phospholipids oxidize more quickly because they contain unsaturated fatty acids. Phospholipids are composed of an amino-alcohol sphingosine/glycerol backbone, a phosphate group, and a hydrophilic residue. Phosphatidyl serine and phosphatidylcholine are examples of phospholipids. The lipid bilayer is made up of phospholipids. Micelles are created when phospholipids are exposed to a lipid-based environment; the phospholipid head and tail self-assemble during this process. The ability of phytosomes to aggregate was one of their unique characteristics.[9]

Name of phospolipids	Role of phospolipid	Structure
Phosphatidylcholine (PC)	More unsaturated fatty acids operate to promote fluidity, and phosphatidylcholine, a fatty acyl composition, is essential for controlling the physical characteristics of membernes.
Phosphatidylethanolamine(PE)	It is crucial for the assembly of other membrane proteins, including lactose permease. It serves as a "chaperone," assisting membrane proteins in appropriately retaining their tertiary structures for optimal activity.
Phosphatidylserine(PS)	Up to 10% of the total cellular lipid is made up of phosphatidylserine (PtdSer), the most prevalent anionic phospholipid in eukaryotic cells and a crucial component of eukaryotic membranes. The role that exofacial PtdSer plays in blood coagulation and apoptosis accounts for a large portion of our knowledge about PtdSer.
Phosphatidic acid(PA)	An established second messenger with direct biological effects, phosphatidic acid is the most basic (diacyl)glycerophospholipid found in cells. In all eukaryotes, it is crucial for membrane fluidity and cellular signaling and is particularly recognized by a variety of proteins.
Phosphatidylinositol(PI)	as a modulator of membrane function and structure. as a source of arachidonic acid for the synthesis of eicosanoid. as a modulator of the reactions of cells to outside stimuli. The modulation of membrane-associated enzymes and transport mechanisms has been suggested to be an active function of phosphatidylinositol.
Phosphatidylglycerol(PG)	Apart from facilitating photosynthesis in cyanobacteria like Synechocystis sp., phosphatidylglycerol plays a crucial function in controlling enzymes involved in respiration, metabolism, transport, transcription, and translation.

MERITS OF PHYTOSOMES

• Phytosomes have better stability due to strong chemical bonding with lipid and enhance the time period  of action.
• Phytosomes are widely used in cosmetic due to more skin penetration and high lipid profile.
• Phytosomes enhace the solubility of Bile to herbal constituent.
• A small amount of dose can yield desired effect when absorption improves.
• Phytosomes has high nutritional value so use as hepatoprotective
• Process of manufacturing of phytosomes is relatively simple.
• Its has high market demand for product. 
• There is no problem with drug entrapment during formulation preparation.
• It offers the cost effective delivery system.
• The formulation of phytosomes is safe and simple to use.[7] [10][5][11]

DEMERITS OF PHYTOSOMES

• Phytoconstituent is quickly eliminated from phytosomes.
• When administrated orally or tropically they reduce their bioavability.
• Stability problem due to leaching. [12]

APPLICATION[13]

MECHANISM OF FORMATION OF PHYTOSOME:

When combined with phosphatidylcholine, the polyphenolic components of herbal essence proved to be reasonably beneficial. A stoichiometric amount of the phospholipid-like phosphatidylcholine reacts with the polyphenolic components, such as simple aprotic solvent containing flavonoids (Bombardelli et al. 1989).

With the phosphatidyl component being lipophilic and the choline component being hydrophilic, phosphatidylcholine is a multifunctional compound. The lipid-soluble phosphatidyl portion, which has a body and tail, covers the choline-bound material after the choline head of the phosphatidylcholine conjugates to these molecules. Thus, a lipid-soluble chemical compound known as the phyto-phospholipid complex is produced by the phytomolecules and phospholipids. Precise spectroscopic techniques can verify that phytomolecules are chemically bonded to the polar choline head of phospholipids (Bombardelli et al. 1991). Often, thorough chemical analysis indicates that a flavonoid molecule linked to at least one phosphatidylcholine molecule is usually the unit phytosome. According to Murray et al. (2008), the result is the formation of a microscopic microsphere or cell. The orange spectrum from phosphatidylcholine obscures the red spectrum from the polyphenol in the blue phytosome spectrum. This is in keeping with the polyphenol being physically trapped by the phosphatidylcholine molecule.[14]

COMMON METHOD:

Phospolipid dissolve in organic solvent

Solution of phospholipid contains organic solvent + drug extract

 

Drying

 

Thin film formation

 

Hydration of thin film

 

Formation of phytosomes complex

 

Isolation by precipitation with non solvent

 

Drying (by lyophilization or spray drying)[15]

1. Solvent Evaporation Method:

A 100 ml round-bottom flask containing the precise amount of medication and polymer was refluxed with an appropriate organic solvent between 50 and 60 degrees for two hours. To acquire the precipitate, which was filtered and collected, the mixture is concentrated to 5–10 ml. The amber colored glass bottle containing the dried precipitate phytosome complexes was kept at room temperature.[16]

2. Rotary Evaporation Technique:

The particular quantity of drug, polymer and phospholipids can be dissolved in specific solvent in a rotary spherical bottom flask followed by stirring for 3 hours at a temperature not exceeding 40oC. Thin film of the sample can be obtained to which n-hexane is added and continuously stirred using a magnetic stirrer. The precipitate phytosome loaded obtained can be collected, placed in amber colored glass bottle and stored at room temperature.[17]

3. Anti solvent Precipitation Technique:

Under particular experimental settings, a specific amount of phospholipids and herbal extract is refluxed with 20 milliliters of organic solvents, such as acetone, for two to three hours below 50°C. After the reaction mixture has been reduced to a minimum volume of 10 milliliters, a solvent is added with low Stirring precipitates with polarity similar to n-hexane are produced. Desiccators are used to hold filtered precipitates. The involute powder is kept at room temperature in a dark amber glass bottle once the dry precipitates have been ground up.[12]

4. Mechanical Dispersion Method:

The lipids that have been dissolved in an organic solvent come into contact with the drug-containing aqueous phase during this process. Diethyl ether is first used to dissolve the phytoconstituents to be encapsulated, and then it is gradually added to a  water-based solution. The organic solvent is then removed under lower pressure, which results in the synthesis of the phytophospholipid complex. New methods for creating phospholipid complexes include supercritical fluids (SCF), which include the gas anti-solvent technique (GAS), supercritical anti-solvent method (SAS), and compressed anti-solvent process (PCA).[18]

5. Salting Out Technique:

An aprotic solvent, like acetone or dioxane, is used to dissolve phosphatidylcholine and phytoconstituents, and the mixture is stirred overnight. After that, the produced complex is precipitated out of a non-solvent, like n-hexane.[18][12]

6. Lyophilization Method:

Following the addition of a medication to soy lecithin (both natural and synthetic phospolipid and phytoconstituent), the mixture refluxes with 20 ml dichloromethane at 60 C, concentrates to 5–10 ml, and then adds 20 ml of hexane to produce the precipitate after filtering. Dry, compress, and run through a hundred sieves.[19]

Some patented technology related to phytosome formation:

EVALUATION OF PHYTOSOME:

1. Partical size determination:

The NANO ZS Malvern instrument's Dynamic Light Scattering was used to measure the phytosomes' particle size, and electrophoretic mobility in an electric field was used to estimate the zeta potential. The determination of particle size was carried out after the phytosomal suspension was diluted 1/100 (v/v) in redistilled water at 25°C. Using the same device, zeta potential was determined at 25°C after the same dilution in a 1 mM NaCl solution.[22]

2. Visualization:

Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) are two methods for seeing phytosomes.

• SEM: The presence of a spheroid or irregular form with rough surface morphology of the phytosomes was shown by the scanning electron microscopy image.
• TEM: One popular instrument for researching nanomaterials is a transmission electron microscope (TEM), which can be used to examine their crystallization, dispersion, and the determination of size. Although extremely crystalline versions of active chemicals can be seen using scanning electron microscopy (SEM), these crystal structures vanish throughout the complexation process. When diluted in distilled water and gently shaken, phyto-phospholipid complexes in TEM analysis display a vesicle-like shape.[23]

3. Drug entrapment efficacy:

Using a direct manner, the resulting phytosomes' entrapment efficiency was assessed 16. Using a centrifuge tube, one milliliter of the phytosome suspension was centrifuged for 60 minutes at 13,000 rpm 4 ^oC. The supernatant and sediment were separated. After being dissolved in 1.0 milliliter of methanol, the sediment was passed through filters with a pore size of 0.45 microns. The following formula was used to calculate the entrapment efficiency (EE), [24]

4. Zeta potential :

The phytosome's surface charge is measured by its zeta potential. It is an important parameter that affects the final product's performance and stability. An argon laser is used in a zeta sizer. To determine the phytosome's zeta potential, dilute the sample with the solvent before mounting it onto the zeta sizer intricate. Phytosome stability over time is indicated by a larger zeta potential value. The unit of measurement is millivolts (mV).[25]The most significant element influencing the physical stability of phytosomes is zeta potential. As the electrostatic repulsion between the particles grows, so does the stability. A scientific analyzer such as the Zetasizer Nano S90 and SZ-100 HORIBA can be used to measure the optimized phytosome's zeta potential.[26]

SPECTROSCOPIC CHARACTERIZATION TECHNIQUE OF PHYTOSOME:

1. Role of phytosome in pancreatic cancer: The combined effects of gemcitabine and the curcumin phytosome were investigated in advanced pancreatic cancer in a prospective Phase II study. 44 patients with metastatic or locally advanced pancreatic cancer were enrolled and administered gemcitabine (10 mg/m2/min) over the course of 100 minutes on days every 28 days) in addition to four capsules that contain 500 mg of doxorubicin (2000 mg/die) each. The primary objective of this trial was to increase the response rate; the secondary objectives were tolerability, overall survival, progression-free survival, and quality of life. The results of the study suggest that pancreatic cancer may benefit from the usage of curcumin phytosomes in conjunction with gemcitabine.
2. Roles of phytosomes in wound healing: Even with advancements in tissue regeneration techniques, challenging situations might arise from immunocompromised states, subsequent infections, and protracted wound healing. A promising method for wound healing is provided by phytosomes, which are lipid-based nanoparticles that contain substances obtained from plants. In this regard, it has been shown that sinigrin-phytosomes significantly accelerate wound healing in human keratinocytes (HaCaT). At 42 hours, sinigrin-phytosomes completely (100%) healed the wound in comparison to sinigrin alone. Al-Samydai et al. evaluated pegylated phytosomes' capacity to promote wound healing in periodontal ligament fibroblasts. The healing process was significantly enhanced by pegylated phytosomes containing 6-gingerol. Phytosomes inhibited the expression of pro-inflammatory mediators in breast cancer cells in contrast to 6-gingerol alone.

Demir et al. created Calendula officinalis augmented phytosomes and assessed their capacity to promote wound healing. Compared to Calendula officinalis and ordinary phytosomes, phytosomes enhanced wound closure in normal human dermal fibroblasts by more than 50%. In a different study, Onosma echioides phytosomes (gel) significantly accelerated wound healing (>98%) in the Wistar rat excision models as compared to the control and standard. Phytosomes also significantly boosted the amount of collagen in comparison to the control group. Successful collagen production is indicated by increases in hydroxyproline levels.In both excision and incision wound models, it is clear that phytosomes enhance the wound-healing capabilities of phytochemicals (both in vivo and in vitro). Because of their enhanced bioavailability, phytopharmaceuticals are the subject of intense research, particularly the creation of phytosomes from plant extract and its constituents. Some of the most current studies on phytosomes in medication delivery were compiled by Susilawati et al.[29]

3. Role of phytosome in transdermal disease:

One of the most popular flavonoids, rutin (Ruta graveolens), was researched by Malay K. Das et al. in 2004. It is used to treat blood and liver problems, capillary fragility, hypertension, and UV-induced cutaneous oxidative stress. cardiovascular disease, cholesterol, cataracts, and possesses anti-inflammatory, antithrombotic, antiplatelet, antioxidant, and antitumor qualities. It was demonstrated that rutin phytosomes were more effective than their free form at penetrating the impenetrable stratum corneum. The skin absorbed 33 ± 1.33 percent of rutin phytosomes and 13 ± 0.87 percent of rutin. 27 The phytosomal complex of saponins and plant extracts (Panax ginseng M.) was shown to improve vasal protection, capillary permeability, and UV radiation protection.

Additionally useful in the creation of pharmaceutical formulations for dermatology and cosmetics, it has a moisturizing effect on the epidermis, increasing its elasticity through dermal fibroblastic stimulation that promotes the synthesis of collagen and proteoglycan. In particular, the aforementioned compositions can be used orally as tablets, capsules, syrups, granules, and solutions (containing a dose of the complex ranging from 1 to 500 mg) to treat inflammation, altered capillary fragility and permeability, and generally in any field where saponin activity is currently known.[30]

Role of phytosome in Diabetics: After 15 days, the polyherbal phytosomal formulation treatment showed exceptional glycemic control in diabetic rats, as evidenced by a significant drop (p < 0.001) in fasting blood glucose levels, which is comparable to metformin treatment.100 mg/kg body weight was administered to rats. When administered to diabetic rats at a dose of 250 mg/body weight, the methanolic mixed extract of all plants dramatically lowers blood glucose levels. Interestingly, the polyherbal phytosomes demonstrated comparable efficacy to the reference medication. However, because there can be a trace quantity of active ingredient in the extract, the larger concentration of the extract was used versus the reference medication. Diabetic rats also showed a considerable rise in body weight. As the formulation of phytosomes increases over time, the weights of diabetic rats rise noticeably.[31]

CONCLUSION

Phytosome technology bridges the gap between novel drug delivery system and traditional delivery system of phytoconstituent. Phytosomes, which are made up of herbal extract and phytoconstituents that are encased and bound by lipid, are the technology used in phytopharmaceuticals. NDDS primarily uses phytosomes to improve the solubility and bioavailability of phytoconstituents. A new and improved type of botanical and phytoconstituent, phytosomes are absorbed orally, tropically, and transdermally. The pharmacokinetic and pharmacological characteristics are also enhanced by phytosomes. Phytosomes' chemical, biological, and physicochemical characteristics are beneficial to the body.Phytosomes have significant anti-inflammatory, anti-cancer, anti-dermal, antioxidant, and anti-hypertensive properties. When phosphatidycholne and phytoconstituents like flavonoids react in a solvent, a compound known as a phytosome is created. The phytosome preparation process is easy to use, repeatable, and readily scaled up to at commercial level. Numerous patents for creative phytosome composition, methods, and applications have already been granted.The methodology for characterization and assessment using analytical techniques like FTIR, DSC, and NMR is well-established for this kind of innovative delivery system. Diabetes mellitus, cardiovascular disease, skin disorders, and other gastrointestinal disorders should all be treated with phytosome technology. In terms of phytosome technology's potential, it has been agreed to be used in the formulation of hydrophilic plant constituents in the future.

REFERENCES

1. R. P. Singh, H. V Gangadharappa, and K. Mruthunjaya, “Phytosome Loaded Novel Herbal Drug Delivery System: a Review,” Int. Res. J. Pharm., vol. 7, no. 6, pp. 15–21, 2016, doi: 10.7897/2230-8407.07656.
2. V. Devi, N. Jain, and K. Valli, “Importance of novel drug delivery systems in herbal medicines,” Pharmacogn. Rev., vol. 4, no. 7, pp. 27–31, 2010, doi: 10.4103/0973-7847.65322.
3. Mahadev B. Khanzode, Archana D. Kajale, Madhuri A. Channawar, and Shilpa R. Gawande, “Review on phytosomes: A novel drug delivery system,” GSC Biol. Pharm. Sci., vol. 13, no. 1, pp. 203–211, 2020, doi: 10.30574/gscbps.2020.13.1.0345.
4. R. P. Singh, S. Parpani, R. Narke, and R. Chavan, “Asian Journal of Pharmaceutical Research and Development PHYTOSOME: RECENT ADVANCE RESEARCH FOR NOVEL DRUG DELIVERY SYSTEM,” Asian J. Pharm. Res. Dev., vol. 2, no. 3, pp. 15–29, 2014, [Online]. Available: www.ajprd.com
5. D. Sharma and A. A. Bhujbale, “Phytosomes is a Novel Drug Delivery System based herbal formulation : An Review,” vol. 6, no. 3, pp. 6–9, 2018.
6. J. Patel, R. Patel, K. Khambholja, and N. Patel, “An overview of phytosomes as an advanced herbal drug delivery system,” Asian J. Pharm. Sci., vol. 4, no. 6, pp. 363–371, 2009.
7. A. Kumar, B. Kumar, S. K. Singh, B. Kaur, and S. Singh, “A review on phytosomes: Novel approach for herbal phytochemicals,” Asian J. Pharm. Clin. Res., vol. 10, no. 10, pp. 41–47, 2017, doi: 10.22159/ajpcr.2017.v10i10.20424.
8. M. Lu et al., “Phyto-phospholipid complexes (phytosomes): A novel strategy to improve the bioavailability of active constituents,” Asian J. Pharm. Sci., vol. 14, no. 3, pp. 265–274, 2019, doi: 10.1016/j.ajps.2018.05.011.
9. V. Krishnaswami, S. Regunathan, and B. Natarajan, “Phytosomes , an Emerging Platform for Herbal Based Drug Delivery,” vol. 14, no. 1, pp. 1–18, 2025.
10. T. Amin, S. Bhat, and S. Vikas Bhat, “A Review on Phytosome Technology as a Novel Approach to Improve The Bioavailability of Nutraceuticals,” Int. J. Adv. Res. Technol., vol. 1, pp. 1–15, 2012, [Online]. Available: https://www.researchgate.net/publication/232244782
11. K. C. Sriya, D. Sai, P. R. Sankar, and A. P. State, “Review Article Phytosomes: A Novel Approach for Herbal Phytochemicals for Enhancing the Bioavailability,” vol. 60, no. 04, pp. 21–26, 2020.
12. V. Gaurav, S. Paliwal, A. Singh, S. Pandey, and M. Aqil, “Phytosomes : Preparation , Evaluation and Application,” vol. 9, no. 2, pp. 35–39, 2021.
13. M. Barani et al., Phytosomes as Innovative Delivery Systems for Phytochemicals : A Comprehensive Review of Literature Phytosomes as Innovative Delivery Systems for Phytochemicals : A Comprehensive Review of Literature. 2021. doi: 10.2147/IJN.S318416.
14. C. K. Nimbalkar and K. Hatware, “Phytosomes - novel drug delivery system,” vol. 5, no. 1, pp. 16–36, 2017.
15. H. A. Pawar, B. D. Bhangale, H. A. Pawar, B. Dilip, B. Phytosome, and N. Biomedicine, “Phytosome as a Novel Biomedicine : A Microencapsulated Drug Delivery System To cite this version : HAL Id : hal-04021033 Bioanalysis & Biomedicine Phytosome as a Novel Biomedicine : A Microencapsulated Drug Delivery System,” 2023, doi: 10.4172/1948-593X.1000116.
16. J. Dwivedi, “Progressive Journey of Phytosomes : Preparation , Characterization , Patents , Clinical trials & Commercial products,” vol. 27, no. 5, pp. 1687–1733, 2023.
17. S. n K S, A. J. Nesalin J, and T. Mani T, “Preparation and Evaluation of Curcumin Phytosomes by Rotary Evaporation Method,” Int. J. Pharm. Biomed. Eng., vol. 6, no. 1, pp. 29–34, 2019, doi: 10.14445/23942576/ijpbe-v6i1p104.
18. A. Kumar, K. Kushwaha, R. Rohit, and P. Ahirwar, “Phytosomes: Innovative Approach To Enhance the Bioavailability and Therapeutic Efficacy of Herbal Extract 1,” World J. Pharm. Med. Res. www.wjpmr.com │, vol. 9, no. 8, p. 240, 2023, [Online]. Available: www.wjpmr.com
19. S. K. M et al., “Phytosomes: nature’s secret to enhanced bioavailability,” vol. 12, no. 6, pp. 88–99, 2024.
20. S. B. Prasad, S. Bhatiya, and S. Singh, “Journal of Chemical and Pharmaceutical Research , 2016 , 8 ( 5 ): 664-670 Review Article Phytosome : Phytoconstituent based lipid derived drug delivery system,” vol. 8, no. 5, pp. 664–670, 2016.
21. S. Sharma and N. Gupta, “Review On Phytosomes: As A Emerging Strategy To Improve The Bioavailability Of Phytoconstituents,” Am. J. PharmTech Res., vol. 10, no. 5, pp. 121–134, 2020, doi: 10.46624/ajptr.2020.v10.i5.009.
22. S. Sharma and A. Sahu, “Development, Characterization, and Evaluation of Hepatoprotective effect of Abutilon indicum and Piper longum Phytosomes,” Pharmacognosy Res., vol. 8, no. 1, pp. 29–36, 2016, doi: 10.4103/0974-8490.171102.
23. S. R. S. Reddy and A. K. Sharma, “Characterization , properties and formulation of Phytosomes,” vol. 4, no. 2, pp. 229–234, 2022.
24. R. Anggraini, S. Surini, and F. C. Saputri, “Formulation and characterization of bitter melon (Momordica charantia Linn.) fruit fraction loaded solid lipid nanoparticles,” Pharmacogn. J., vol. 13, no. 6, pp. 1347–1354, 2021, doi: 10.5530/PJ.2021.13.170.
25. K. P and K. R, “Phytosome Technology: A Novel Breakthrough for the Health Challenges,” Cureus, vol. 16, no. 8, 2024, doi: 10.7759/cureus.68180.
26. S. G. Jagtap, V. V. Kajale, M. M. Abhyankar, A. S. Kulkarni, and M. R. Ghante, “Formulation and Evaluation of Phytosomes of Hydroalcoholic Extract of Adiantum capillus-veneris for Antimicrobial Activity,” Pharmacognosy Res., vol. 15, no. 3, pp. 468–477, 2023, doi: 10.5530/pres.15.3.048.
27. S. Saha, A. Sarma, P. Saikia, and T. Chakrabarty, “Phytosome : A Brief Overview Phytosome : A Brief Overview,” no. October, 2015.
28. D. R. Telange, A. T. Patil, A. M. Pethe, H. Fegade, S. Anand, and V. S. Dave, “Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential,” Eur. J. Pharm. Sci., vol. 108, pp. 36–49, 2017, doi: 10.1016/j.ejps.2016.12.009.
29. K. Sakure, A. Patel, M. Pradhan, and H. R. Badwaik, “Review Article Recent Trends and Future Prospects of Phytosomes : A Concise Review,” vol. 86, no. July 2023, pp. 772–790, 2024.
30. P. S. Chivte, V. S. Pardhi, V. A. Joshi, and A. Rani, “a Review on Therapeutic Applications of Phytosomes,” J. Drug Deliv. Ther., vol. 7, no. 5, 2017, doi: 10.22270/jddt.v7i5.1513.
31. S. Rathee and A. Kamboj, “Optimization and development of antidiabetic phytosomes by the Box–Behnken design,” J. Liposome Res., vol. 28, no. 2, pp. 161–172, 2018, doi: 10.1080/08982104.2017.1311913